HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

499.747

-6.328-1.25%

Number of Gainers:7

Number of Losers:24

Number of Flat:2

PE:- -

High:517.538

Open:506.335

Low:496.695

Close:506.075

Volume:58.05M

Turnover:1.69B

Market Cap:318.90B

Float Cap:284.40B

Loading ...

Yiling Receives Notice for Clinical Trial Application of Its New Chemical Drug 'LB220-D08 Extended-Release Tablets'

Zhaoke Ophthalmology Signs Exclusive Distribution Deal with Pharmentum Biopharma for Epinastine Eye Drops in China

Zhaoke Ophthalmology - Enters Exclusive Distribution Agreement with Pharmentum Biopharma in China

THOMSON REUTERS

Zhaoke Ophthalmology - Agreement to Commercialize Epinastine Hydrochloride Eye Drops in China (Excluding Hong Kong, Macau and Taiwan)

THOMSON REUTERS

Alphamab Oncology Schedules Board Meeting to Review Interim Results

JW Cayman Therapeutics Schedules Board Meeting to Review Interim Results

Ningyang County Market Regulation Bureau Launches Special Inspection on Optometry Instruments

Haisco Pharmaceutical Group Receives Clinical Trial Approval for Novel Drug HSK60002 Tablet

Ascletis Pharma (SEHK:1672) At 5x P B On Obesity Trial Momentum Looks About Right

Simply Wall St.

New Batch of National Standards Released, Including Autonomous Driving Safety and AI Medical Device Quality

Hong Kong Stock Market Moves: <b>PEIJIA-B</b> Surges Over 5% as First-Half Revenue Growth Reaches Up to 23% and TaurusTrio Implants Exceed 660 Cases in Mainland China

Hong Kong Stock Movers: MP CARDIOFLOW-B Surges Nearly 5% on Strong Guidance and Global Growth

Zai Lab shares surge over 5% at midday as proprietary assets enter clinical value validation phase

Expanding Overseas, Earnings Validation, and AI Integration: China's Innovative Drug Sector Continues Its Recovery, with T+0 Huatai-PineBridge Hang Seng Innovation Drug ETF (520500) Seeing 77% Growth in Shares This Year

MicroPort CardioFlow Sees Net Loss of Up to $25 Million in H1

MT Newswires Live

Pharmaceutical Research Surpasses Semiconductor in Interest, Innovative Drug Sector Retreats, Huabao Fund's Hong Kong Biotech ETF Falls Below Key Moving Average, CXO Shows Resilience with WuXi Companies Rising Against the Trend

New Drug Popular Stock Surges to Daily Limit in 2 Minutes

Hong Kong Stock Market Opening: Hang Seng Index Opens 0.6% Lower, Gold Stocks Rise, ZAI LAB Surges Over 8%

August Fund Launch Supply Dips, Healthcare Sector Attracts Contrarian Investment

Asian Penny Stocks To Consider In August 2026

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK1574/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":499.7466,"timestamp":1787543998559,"preClose":506.0749,"halted":0,"volume":58046044,"delay":0,"changeRate":-0.012505,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Noon Closed","change":-6.328278,"latestTime":"08-24 12:00:00","open":506.33536,"high":517.53845,"low":496.69476,"amount":1691833851,"amplitude":0.041187,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787547600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"pbRate":4.109535,"peRate":-81.157718,"turnoverRate":0.002107,"increases":7,"decrements":24,"flats":2,"marketCap":318900946064,"floatMarketCap":284404466328},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":517.53845,"amplitude":0.041187,"preClose":506.0749,"low":496.69476,"pbRate":"4.109535","latestPrice":499.7466,"volume":58046044,"delay":0,"open":506.33536,"prevYearClose":556.26263,"prevWeekClose":506.075,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":505.128,"twentyDayClose":497.839,"sixtyDayClose":520.536,"secType":"PLATE","market":"HK","turnoverRate":0.002107,"peRate":-81.157718,"marketCap":318900946064,"floatMarketCap":284404466328,"timestamp":1787543998559,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":7,"down":24,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197098611","title":"Yiling Receives Notice for Clinical Trial Application of Its New Chemical Drug 'LB220-D08 Extended-Release Tablets'","url":"https://stock-news.laohu8.com/highlight/detail?id=1197098611","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197098611?lang=en_us&edition=fundamental","pubTime":"2026-08-12 17:08","pubTimestamp":1786525684,"startTime":"0","endTime":"0","summary":"Shijiazhuang Yiling Pharmaceutical Co.,Ltd. (002603.SZ) has announced that it recently received the \"Acceptance Notice\" from the National Medical Products Administration (NMPA) for the drug named...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002603","BK0042","159992","BMED","BK0188","BK0097","LNGR","BK1161","BK0239","MDTX","IBBQ","BK1574","IBBJ","MEDX","06978","PSYK","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978528","title":"Zhaoke Ophthalmology Signs Exclusive Distribution Deal with Pharmentum Biopharma for Epinastine Eye Drops in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978528","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658978528?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:55","pubTimestamp":1786524908,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology signs exclusive distribution deal with Pharmentum Biopharma for epinastine eye drops in ChinaZhaoke Ophthalmology entered a five-year exclusive distribution and promotion deal wit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL4MYV5S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622","BK1574","BK1191","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978534","title":"Zhaoke Ophthalmology - Enters Exclusive Distribution Agreement with Pharmentum Biopharma in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978534","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658978534?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:54","pubTimestamp":1786524877,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06622","BK1191","BK1583","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658785379","title":"Zhaoke Ophthalmology - Agreement to Commercialize Epinastine Hydrochloride Eye Drops in China (Excluding Hong Kong, Macau and Taiwan)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658785379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658785379?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:54","pubTimestamp":1786524877,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490PQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06622","BK1191","BK1583","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658920308","title":"Alphamab Oncology Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920308","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658920308?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:36","pubTimestamp":1786523777,"startTime":"0","endTime":"0","summary":"Alphamab Oncology schedules board meeting to review interim resultsAlphamab Oncology scheduled a board meeting for Aug. 27, 2026 to review interim results for the six months ended June 30, 2026.Discla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL4YBHQZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658920887","title":"JW Cayman Therapeutics Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920887","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658920887?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:32","pubTimestamp":1786523552,"startTime":"0","endTime":"0","summary":"JW Cayman Therapeutics schedules board meeting to review interim resultsJW Cayman Therapeutics scheduled a board meeting for Aug. 27, 2026 to review unaudited interim results for the six months ended ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL6D8VqW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02126","BK1574","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126627296","title":"Ningyang County Market Regulation Bureau Launches Special Inspection on Optometry Instruments","url":"https://stock-news.laohu8.com/highlight/detail?id=1126627296","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126627296?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:32","pubTimestamp":1786523522,"startTime":"0","endTime":"0","summary":"On August 11, enforcement officers from the Ningyang County Market Regulation Bureau in Shandong Province conducted a special medical device inspection at eyewear retail stores in the area. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEIH","BK1574","LNGR","HART","PTH","AGNG","09996","MEDX","MDEV","RSPH","BK1100","BK1583","GDOC","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177259314","title":"Haisco Pharmaceutical Group Receives Clinical Trial Approval for Novel Drug HSK60002 Tablet","url":"https://stock-news.laohu8.com/highlight/detail?id=1177259314","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177259314?lang=en_us&edition=fundamental","pubTime":"2026-08-12 15:54","pubTimestamp":1786521254,"startTime":"0","endTime":"0","summary":"Haisco Pharmaceutical Group Co.,Ltd. (002653.SZ) announced that it has received a Drug Clinical Trial Approval Notice from the National Medical Products Administration. The review found that the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LNGR","MEDX","PSYK","002653","BMED","BK1161","159992","IBBJ","BK0028","BK0033","BK0077","BK1574","MDTX","BK0239","BK0188","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658128927","title":"Ascletis Pharma (SEHK:1672) At 5x P B On Obesity Trial Momentum Looks About Right","url":"https://stock-news.laohu8.com/highlight/detail?id=2658128927","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658128927?lang=en_us&edition=fundamental","pubTime":"2026-08-12 15:30","pubTimestamp":1786519859,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (SEHK:1672) has drawn fresh attention after launching two Phase I obesity trials in the U.S. and starting a global Phase III program for its oral GLP-1 candidate ASC30.\nSee our latest analysis for Ascletis Pharma.\nThe recent obesity pipeline updates arrive after a mixed share price run for Ascletis Pharma. The stock rose 13.29% over a 7 day share price return but remains down 37.61% over a 90 day share price return and has recorded a 26.41% decline on the 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-at-5x-p-b-on-obesity-trial-momentum","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-at-5x-p-b-on-obesity-trial-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1515","01672","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119178651","title":"New Batch of National Standards Released, Including Autonomous Driving Safety and AI Medical Device Quality","url":"https://stock-news.laohu8.com/highlight/detail?id=1119178651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119178651?lang=en_us&edition=fundamental","pubTime":"2026-08-12 15:21","pubTimestamp":1786519304,"startTime":"0","endTime":"0","summary":"A significant set of 338 national standards has been approved by the State Administration for Market Regulation's Standardization Administration.This release includes 15 mandatory and 323 recommended...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02834","09834","TECY","FWD","MOTO","BK1583","QID","PBOT","CARZ","QQA","PSQ","PTH","BK1574","07261","MFIG","HAIL","AIQU","WPAI","07568","QMAR","SQQQ","DRIV","CWC","NEWZ","IEIH","07266","QTOC","NJUL","FDIF","DQJN","TQQQ","159883","GK","CHAT","QQQX","RSPH","MEDX","AIBU","QDEC","VUSE","NOCT","03086","ROBT","LNGR","IDRV","NBDS","HART","NJAN","QQQM","TQQY","TARK","IQM","LCLG","LGHT","09996","QLD","AGIX","GDOC","CPNQ","161631","AIFD","NAPR","ARTY","BK1100","BK4593","MDEV","AGNG","GPIQ","AQGX","QSWN","QQQ","07522","FAI","03455","09086","XT","OGIG","03034","KOMP","MVPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169051698","title":"Hong Kong Stock Market Moves: <b>PEIJIA-B</b> Surges Over 5% as First-Half Revenue Growth Reaches Up to 23% and TaurusTrio Implants Exceed 660 Cases in Mainland China","url":"https://stock-news.laohu8.com/highlight/detail?id=1169051698","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169051698?lang=en_us&edition=fundamental","pubTime":"2026-08-12 14:35","pubTimestamp":1786516500,"startTime":"0","endTime":"0","summary":"PEIJIA-B (09996) shares rose more than 5% in trading, currently up 4.75% to HK$5.29, with a turnover of HK$2.8668 million.The company recently disclosed that its first-half revenue is expected to be...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09996","BK4585","BK4588","KCAI","VXUS","BK1100","BK1583","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170215707","title":"Hong Kong Stock Movers: MP CARDIOFLOW-B Surges Nearly 5% on Strong Guidance and Global Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1170215707","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170215707?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:58","pubTimestamp":1786507093,"startTime":"0","endTime":"0","summary":"MP CARDIOFLOW-B (02160) saw its shares climb nearly 5% in early trading on Thursday, rising 4.72% to HK$1.33 with turnover of HK$2.302 million.Driving the rally, the company announced that it expects...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4585","02918","BK1225","BK1239","BK1100","KCAI","HART","BK1583","BK4588","BK1574","02160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194770662","title":"Zai Lab shares surge over 5% at midday as proprietary assets enter clinical value validation phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1194770662","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194770662?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:50","pubTimestamp":1786506622,"startTime":"0","endTime":"0","summary":"Zai Lab Ltd (09688) shares climbed more than 11% in early trading before paring gains, with the stock now up over 30% since its recent earnings report. As of midday, the shares were trading 5.13%...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688","BK4531","BK4548","BK4588","BK1161","ZLAB","BK4585","BK4139","BK1588","BK1574","LU2488822045.USD","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147529953","title":"Expanding Overseas, Earnings Validation, and AI Integration: China's Innovative Drug Sector Continues Its Recovery, with T+0 Huatai-PineBridge Hang Seng Innovation Drug ETF (520500) Seeing 77% Growth in Shares This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1147529953","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147529953?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:46","pubTimestamp":1786506394,"startTime":"0","endTime":"0","summary":"Since the second half of the year, the repair rally in the innovative drug sector has been steadily advancing. A combination of favorable policy signals, accelerated corporate overseas expansion, and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1161","CHAT","LNGR","QTOC","MEDX","520500","AGIX","ARTY","159992","BK1574","AIPO","06978","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658928642","title":"MicroPort CardioFlow Sees Net Loss of Up to $25 Million in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2658928642","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658928642?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:22","pubTimestamp":1786504966,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow Medtech (HKG:2160) expects to record a net loss of no more than $25 million for the first half of 2026, according to a Tuesday filing with the Hong Kong Stock Exchange.The company also expects to post revenue of not less than $153 million for the period.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02160","BK1574","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107205780","title":"Pharmaceutical Research Surpasses Semiconductor in Interest, Innovative Drug Sector Retreats, Huabao Fund's Hong Kong Biotech ETF Falls Below Key Moving Average, CXO Shows Resilience with WuXi Companies Rising Against the Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1107205780","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107205780?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:16","pubTimestamp":1786504593,"startTime":"0","endTime":"0","summary":"On August 12, the previously rising Hong Kong-listed innovative drug supply chain experienced a correction. The medical-themed sector in Hong Kong Stock Connect traded sideways below the waterline,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","09939","BK4535","FTXL","159582","SOXQ","BK4585","MQQQ","SOXS","SOXX","CHPS","06978","WX","SOXL","SOXY","FWD","BK1515","FLHK","NBDS","USD","MEDX","TEKX","PSI","SMHU","CXO","SMH","LNGR","159938","159316","EIS","SMHX","SSG","BK4588","IBBQ","XSD","CHPY","CWC","BK1574","TECY","VGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197460880","title":"New Drug Popular Stock Surges to Daily Limit in 2 Minutes","url":"https://stock-news.laohu8.com/highlight/detail?id=1197460880","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197460880?lang=en_us&edition=fundamental","pubTime":"2026-08-12 10:40","pubTimestamp":1786502437,"startTime":"0","endTime":"0","summary":"Focus: Capital Seeking New Directions, Second-Half 2024 A-Share Investment Landscape EmergesOn August 12, the innovative drug concept strengthened again, with Baihua Pharmaceutical quickly hitting...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1161","BK1574","LNGR","IBBQ","MEDX","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166678236","title":"Hong Kong Stock Market Opening: Hang Seng Index Opens 0.6% Lower, Gold Stocks Rise, ZAI LAB Surges Over 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166678236","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166678236?lang=en_us&edition=fundamental","pubTime":"2026-08-12 09:41","pubTimestamp":1786498911,"startTime":"0","endTime":"0","summary":"The Hang Seng Index opened 0.6% lower at 25,498.39 points on August 12, while the Hang Seng Tech Index fell 0.8% to 4,785.75 points, and the Hang Seng China Enterprises Index dropped 0.57% to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688","BK1574","BK1588","ZLAB","LU2488822045.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158258692","title":"August Fund Launch Supply Dips, Healthcare Sector Attracts Contrarian Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1158258692","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158258692?lang=en_us&edition=fundamental","pubTime":"2026-08-12 07:10","pubTimestamp":1786489855,"startTime":"0","endTime":"0","summary":"August has seen a weakening in the overall supply of new public mutual fund launches, driven by market volatility in July. As of August 11, Wind data shows only 23 new funds were established this...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","159938","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658941781","title":"Asian Penny Stocks To Consider In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658941781","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658941781?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:02","pubTimestamp":1786485727,"startTime":"0","endTime":"0","summary":"As Asian markets navigate a complex landscape marked by geopolitical developments and economic shifts, investors are increasingly looking beyond traditional blue-chip stocks for growth opportunities. Penny stocks, while often associated with smaller or newer companies, continue to capture attention as they offer potential for significant returns at lower price points. Despite being considered a somewhat outdated term, these investments can still present compelling opportunities when backed by...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-9860/adicon-holdings-shares/news/asian-penny-stocks-to-consider-in-august-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-9860/adicon-holdings-shares/news/asian-penny-stocks-to-consider-in-august-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK1161","01167","BK4588","SPHQ","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":12,"totalSize":279,"code":"91000000","status":"200"}]}}